Apnimed
APMD25.0000.00% ( 0.000 )
Apnimed (APMD)
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related b...
- Open
- 24.290
- High
- 27.910
- Low
- 22.350
- Prev. Close
- 25.000
- Volume
- 700.68K
- Turnover
- 18.03M
- Avg Price
- 25.739
- Bid/Ask Ratio
- --
- Amplitude
- 22.24%
- 52wk High
- 29.150
- Volume Ratio
- 0.00
- Turnover Ratio
- 3.08%
News
- Tip Ranks · 5 hours ago
Insider Move: Apnimed Director Makes Bold New Investment
- IPO Scoop · 3 hours ago
The IPO Buzz: Biotechs Turn Up the Heat in August
- PUBT · 11 hours ago
Apnimed adopts new IPO-era bylaws with advance notice rules for shareholder proposals
- PUBT · 11 hours ago
Apnimed director Paul J. Sekhri acquires $200,000 in common shares
- StockTitan · 18 hours ago
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares | APMD Stock News
- benzinga_article · 19 hours ago
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
